InsiderSignal.AI

InsiderSignal.ai

SLDB - Solid Biosciences Inc.

Insider Sale by Tan Kevin (CFO, Treasurer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Tan Kevin, serving as CFO, Treasurer at Solid Biosciences Inc. (SLDB), sold 5,404 shares at $5.82 per share, for a total transaction value of $31,469.00. Following this transaction, Tan Kevin now holds 99,422 shares of SLDB.

This sale represents a 5.00% decrease in Tan Kevin's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, meaning the disclosure happened on the same day as the trade.

Solid Biosciences Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Tan Kevin

CFO, Treasurer

Kevin Tan is the Chief Financial Officer and Treasurer of Solid Biosciences Inc. (SLDB), a position he has held since January 9, 2023.[[1]](https://fintool.com/app/research/companies/SLDB/people/kevin-tan)[[2]](https://www.marketscreener.com/insider/KEVIN-TAN-A3C0B0/)[[4]](https://contracts.justia.com/companies/solid-biosciences-inc-5882/contract/1284183/) Based in the Boston area, he oversees financial operations for the company, reporting to the CEO and board, and is subject to a comprehensive employment agreement including non-compete clauses, severance provisions, and equity incentives.[[1]](https://fintool.com/app/research/companies/SLDB/people/kevin-tan)[[4]](https://contracts.justia.com/companies/solid-biosciences-inc-5882/contract/1284183/)[[5]](https://rocketreach.co/kevin-tan-email_372736484) Tan, aged 47 as of April 2025, brings extensive experience in biotech and finance, with prior roles as CFO at Selecta Biosciences (2021–2022), Treasurer and Assistant Treasurer at Sarepta Therapeutics (2018–2021), and Senior Portfolio Manager at CPP Investments (2012–2016), alongside positions at Macquarie, Arrowhawk, and Lehman/Barclays.[[1]](https://fintool.com/app/research/companies/SLDB/people/kevin-tan)[[2]](https://www.marketscreener.com/insider/KEVIN-TAN-A3C0B0/) He holds a B.Comm from Queen’s University, an M.Eng from Princeton University, an MBA from Chicago Booth, and is a CFA charterholder.[[1]](https://fintool.com/app/research/companies/SLDB/people/kevin-tan)[[2]](https://www.marketscreener.com/insider/KEVIN-TAN-A3C0B0/) Recently, Tan executed an automatic sale of 14,783 SLDB shares on February 4, 2026, to cover tax withholding on vested RSUs under a Rule 10b5-1 plan.[[3]](https://www.sahmcapital.com/news/content/solid-biosciences-cfo-kevin-tan-reports-disposal-of-common-shares-2026-02-07)[[6]](https://www.stocktitan.net/sec-filings/SLDB/form-4-solid-biosciences-inc-insider-trading-activity-d55e6f58999c.html)

View full insider profile →

Trade Price

$5.82

Quantity

5,404

Total Value

$31,469.00

Shares Owned

99,422

Trade Date

Wednesday, February 18, 2026

4 days ago

SEC Filing Date

Wednesday, February 18, 2026

HEALTHCAREBIOTECHNOLOGY

About Solid Biosciences Inc.

Company Overview

No company information available
View news mentioning SLDB

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4101951

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime